03-Apr-2026
Download PDF
Bliss GVS Pharma
We would like to inform you that based on the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Company has approved and passed the resolutions by circulation on April 03 2026 as enclosed herewith.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
